Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03503370 · ClinicalTrials.gov registry record · Phase 2
Preventing Diabetic Foot Ulcers Through Cleaner Feet
A Phase 2 study, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- Phase 2
- Development phase
- 175
- Enrollment target
NCT03503370: Completed Phase 2 study, sponsored by VA Office of Research and Development.
NCT03503370 is a Phase 2 study that has completed, run by VA Office of Research and Development. The registered enrollment target is 175 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03503370, a Phase 2 study, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 175 participants
- Enrollment target
Study Summary
Foot complications are among the most serious and costly complications of diabetes. People with diabetes have a 10-fold increased risk for a leg or foot amputation compared to those that do not have diabetes. Amputation of all or part of foot is usually preceded by a foot ulcer, which became infected. This is a clinical trial to test the effectiveness of a topical antiseptic, chlorhexidine, for daily foot cleaning on the occurrence of diabetic foot ulcers in Veterans at high risk of a diabetic foot ulcer.
Interventions
- DRUG Placebo
- DRUG Chlorhexidine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 175 participants |
| Start Date | 2019-01-02 |
| Est. Completion | 2023-01-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03503370
The ClinicalTrials.gov registry entry for NCT03503370 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 175 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT03503370 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03503370 about?
NCT03503370 is a clinical study titled "Preventing Diabetic Foot Ulcers Through Cleaner Feet". Foot complications are among the most serious and costly complications of diabetes. People with diabetes have a 10-fold increased risk for a leg or foot amputation compared to those that do not have diabetes. Amputation of all or part of foot is usually preceded by a foot ulcer, which became infecte...
What is the current status of trial NCT03503370?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 175 participants. The study started on 2019-01-02. Estimated completion is 2023-01-06.
What interventions are being tested in trial NCT03503370?
The interventions under investigation include: Placebo (DRUG), Chlorhexidine (DRUG).
Who is sponsoring clinical trial NCT03503370?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.